<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref6">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cuypers</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Snoeck</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kerremans</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Libin</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Crabbe</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Van Dooren</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2016</year>). 
  <article-title>HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial</article-title>. 
  <source>Infect. Genet. Evol.</source>
  <volume>44</volume>, 
  <fpage>169</fpage>â€“
  <lpage>181</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.meegid.2016.06.050</pub-id>, PMID: 
  <?supplied-pmid 27374748?>
  <pub-id pub-id-type="pmid">27374748</pub-id>
 </mixed-citation>
</ref>
